focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 35.00
Ask: 35.25
Change: -0.20 (-0.57%)
Spread: 0.25 (0.714%)
Open: 35.50
High: 35.50
Low: 35.00
Prev. Close: 35.20
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

19 Apr 2021 15:09

RNS Number : 9309V
Alliance Pharma PLC
19 April 2021
 

TR-1: Standard form for notification of major holdings

 

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Alliance Pharma Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Details of person subject to the notification obligation

Name

MVM Partners LLP

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)

Name

MVM Fund III LP, MVM Fund III (no 2) LP

City and country of registered office (if applicable)

London, UK

5. Date on which the threshold was crossed or reached:

16/04/2021

6. Date on which issuer notified (DD/MM/YYYY):

19/04/2021

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

2.6%

 

2.6%

534,011,603

Position of previous notification (if

applicable)

3.9%

 

3.9%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0031030819

13,831,383

 

2.6%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdate

Exercise/Conversion Period 

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)

 

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information

 

     

 

Place of completion

London, UK

Date of completion

19th April 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALLNFEKFEFA
Date   Source Headline
17th Nov 201610:40 amRNSExercise of Share Options
28th Oct 20165:13 pmRNSShare Options
28th Oct 20167:00 amRNSAppointment of Deputy CEO
5th Oct 20166:00 pmRNSExercise of Share Options
23rd Sep 20167:01 amRNSExercise of Share Options
23rd Sep 20167:00 amRNSDirector Dealings
14th Sep 20167:00 amRNSInterim Results
13th Sep 20167:00 amRNSNew Agreement for Diclectin in Europe
18th Aug 20167:00 amRNSInterim Results Analyst Meeting - Change of Time
8th Aug 20165:00 pmRNSExercise of Share Options
2nd Aug 20167:00 amRNSNotification of Interim Results
26th Jul 20167:00 amRNSExercise of Share Options
19th Jul 20167:00 amRNSHalf Year Trading Update
12th Jul 20167:00 amRNSNotification of Half Year Trading Update
25th May 201611:15 amRNSResult of AGM
25th May 20167:00 amRNSAGM Statement
24th May 20167:00 amRNSExercise of Share Options
5th May 20161:30 pmRNSDirector Shareholding
3rd May 20167:00 amRNSExercise of Share Options
28th Apr 20167:00 amRNSAnnual Report and AGM Notice
7th Apr 20167:00 amRNSPreliminary Results
18th Mar 20167:00 amRNSNotification of Preliminary Results
3rd Mar 20167:00 amRNSHardman & Co Research Report
5th Feb 20163:57 pmRNSExercise of Share Options
22nd Jan 20163:45 pmRNSExercise of Share Options
21st Jan 20167:00 amRNSPre-Close Trading Update
12th Jan 20162:34 pmRNSNotification of Major Interest in Shares
7th Jan 20161:56 pmRNSNotification of Major Interest in Shares
23rd Dec 201512:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Dec 20154:40 pmRNSDirector Shareholding
18th Dec 20155:15 pmRNSNotification of Major Interest in Shares
18th Dec 20154:20 pmRNSNotification of Major Interest in Shares
18th Dec 20153:54 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th Dec 20153:39 pmRNSNotification of Major Interest in Shares
17th Dec 20153:13 pmRNSNotification of Major Interest in Shares
17th Dec 20159:00 amRNSCompletion of Acquisition and Placing
14th Dec 20154:00 pmRNSResult of General Meeting
8th Dec 20155:41 pmRNSNotification of Major Interest in Shares
7th Dec 20157:00 amRNSShare Options
3rd Dec 20152:03 pmRNSPlacing Update: Exercise of Broker's Option
2nd Dec 20158:00 amRNSSchedule 1 - Alliance Pharma Plc
26th Nov 20154:35 pmRNSInterim Dividend Timetable
26th Nov 20157:00 amRNSProposed Acquisition
23rd Nov 20154:00 pmRNSDirectorate Change
5th Nov 20157:00 amRNSSettlement Agreement
10th Sep 20157:00 amRNSInterim Dividend Timetable - Record Date
9th Sep 20157:00 amRNSInterim Results
2nd Sep 20156:01 pmRNSNotification of Major Interest in Shares
21st Aug 20158:45 amRNSExercise of Share Options
17th Aug 20157:00 amRNSNotification of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.